# Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS

> **NCT04166929** · PHASE2 · TERMINATED · sponsor: **Fondazione Policlinico Universitario Agostino Gemelli IRCCS** · enrollment: 6 (actual)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplasia

## Interventions

- **BIOLOGICAL:** Haplo SCT with NK cells
- **BIOLOGICAL:** Haplo SCT

## Key facts

- **NCT ID:** NCT04166929
- **Lead sponsor:** Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-01-15
- **Primary completion:** 2023-09-28
- **Final completion:** 2023-09-28
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** low recruitment
- **Last updated:** 2023-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04166929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04166929, "Haploidentical Stem Cell Transplant With or Without NK Cell Infusion in AML and MDS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04166929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*